Weilong Shi

SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials

Jiali Han, S. Zhai, Huilin Tang, 2017, Diabetologia.

Effects of the CYP3A4*1B Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Adult Renal Transplant Recipients: A Meta-Analysis

S. Zhai, Hui-lin Tang, W. Shi, 2015, PloS one.

Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials.

S. Kimmel, K. Cusi, M. Gurka, 2022, Diabetes care.

SGLT2 inhibitor plus DPP‐4 inhibitor as combination therapy for type 2 diabetes: A systematic review and meta‐analysis

Huilin Tang, Tiansheng Wang, Dandan Li, 2018, Diabetes, obesity & metabolism.

Voriconazole exposure and risk of cutaneous squamous cell carcinoma among lung or hematopoietic cell transplant patients: A systematic review and meta-analysis.

Jiali Han, Huilin Tang, Yiqing Song, 2019, Journal of the American Academy of Dermatology.

Limited clinical utility of genotype-guided warfarin initiation dosing algorithms versus standard therapy: a meta-analysis and trial sequential analysis of 11 randomized controlled trials

S. Zhai, H. Tang, W. Shi, 2015, The Pharmacogenomics Journal.

Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis

Jiali Han, S. Zhai, Huilin Tang, 2018, Cancer medicine.